Dichlorphenamide

Dichlorphenamide is a medication used to treat glaucoma, which is a condition that increases pressure inside the eye. It works by helping to lower that pressure. It's usually taken as eye drops.

Brand names:Daranide, Keveyis
Medication

What people taking Dichlorphenamide report

Every report comes from a Lived member, sent anonymously.

Have you tried Dichlorphenamide for Hyperkalemic Periodic Paralysis?

NameHow it went

About Dichlorphenamide

What It's For

Dichlorphenamide is a prescription tablet used to prevent attacks of primary periodic paralysis, a group of rare inherited muscle conditions. It is sold in the US as Keveyis and Ormalvi, and as generic dichlorphenamide. It is approved for primary hypokalemic periodic paralysis, primary hyperkalemic periodic paralysis and related variants. It was the first medicine the US Food and Drug Administration (FDA) approved specifically for these conditions. In periodic paralysis, faulty ion channels in the muscles cause episodes of severe weakness or temporary paralysis, most often in the arms and legs, that can last from hours to days. In the hypokalemic form, blood potassium tends to drop during an attack; in the hyperkalemic form, it often rises or stays normal. Attacks can be set off by things like rest after exercise, a large carbohydrate-rich meal or, in the hyperkalemic form, potassium-rich foods. Dichlorphenamide is taken every day to make attacks less frequent, not to stop one already under way. The same drug was once sold under the brand name Daranide to treat glaucoma, but it stopped being marketed for that use around 2002 and is not used for glaucoma today.

How It Works

Dichlorphenamide belongs to a group of drugs called carbonic anhydrase inhibitors. Carbonic anhydrase is an enzyme that helps the body manage acid and bicarbonate, especially in the kidneys. Blocking it makes the kidneys release more bicarbonate, which leaves the blood slightly more acidic, and more potassium. Acetazolamide, an older drug in the same group, is also used for periodic paralysis. Exactly how this reduces paralysis attacks is not known, and the drug does not repair the faulty muscle channels themselves. The same changes in potassium and acid balance also explain several of the drug's main side effects and why blood tests are part of treatment.

Dosage & Administration

Dichlorphenamide comes as a 50 mg tablet taken by mouth. Treatment usually starts at 50 mg once or twice a day, and the prescriber raises or lowers the dose based on how well attacks are controlled and how side effects feel, generally no more often than weekly. The recommended total is between 50 mg and 200 mg a day. In the main trials, people ended up on roughly 75 to 100 mg a day on average. Because the drug can lower potassium and make the blood more acidic, blood tests for potassium and bicarbonate (the body's main acid buffer in the blood) are done before starting and then periodically. Low bicarbonate on these tests signals that the blood has become too acidic. Take it as prescribed every day, since it works by preventing attacks over time rather than as a rescue medicine.

Side Effects

The most common side effect is tingling or pins and needles, usually in the hands, feet or around the mouth, which affected about four in ten people in clinical trials. Other frequent effects are trouble concentrating or memory lapses, confusion, and a changed or metallic taste. Headache, tiredness, dizziness, nausea, muscle cramps and weight loss also occur. Tell the prescriber about thinking or memory problems; a lower dose often helps, and care is needed with driving or operating machinery until you know how the drug affects you. Dichlorphenamide raises the risk of falls, especially in older adults and at higher doses. It can also cause low potassium and metabolic acidosis (blood that is too acidic). Contact the prescriber right away for fast breathing, unusual tiredness, loss of appetite, or an irregular or pounding heartbeat, which can be signs of acidosis or a potassium problem. Dichlorphenamide is a sulfonamide, related to sulfa antibiotics, and rarely causes severe allergic or immune reactions, including serious skin reactions, liver damage and blood disorders. Stop the medicine and contact the prescriber right away at the first sign of a skin rash. Swelling of the face, lips or throat, or trouble breathing, needs emergency care.

Interactions & Warnings

Dichlorphenamide should not be used by people who are allergic to it or to other sulfonamide drugs, people with liver insufficiency (it can worsen confusion caused by liver failure), or people with severe lung disease, whose lungs may not be able to make up for the extra acid in the blood. High-dose aspirin must not be taken with dichlorphenamide, because the combination can cause aspirin poisoning, with loss of appetite, rapid breathing, drowsiness and even coma. Even low-dose aspirin needs careful monitoring, so check with the prescriber before taking aspirin or other salicylates, which are also found in some over-the-counter products. Other medicines that lower potassium add to the risk of low potassium. These include water pills (loop and thiazide diuretics), laxatives, some antifungals and penicillin antibiotics, and theophylline, a breathing medicine. Dichlorphenamide can also raise the levels of certain drugs cleared by the kidneys, so it is not recommended with methotrexate (a drug for cancer and autoimmune disease), famotidine (a stomach acid reducer) or oseltamivir (an influenza medicine). Give the prescriber and pharmacist a full list of medicines and supplements. There are no good human data on use during pregnancy. The drug caused limb defects in rats at high doses, and acidosis during pregnancy can affect the baby's growth and ability to tolerate labor, so anyone pregnant or planning pregnancy should discuss the balance of risks with their specialist. Newborns exposed before birth are checked for acidosis. Its safety and effectiveness have not been established in children.

What to Expect

Dichlorphenamide aims to cut how often attacks happen and how badly they flare, not to cure the underlying condition. In two 9-week trials in adults, people with hypokalemic periodic paralysis had about two fewer attacks a week than those on placebo, and far fewer had to leave the study because attacks became intolerable. Results in hyperkalemic periodic paralysis also favored the drug, though they were less consistent across trials. It did not improve muscle strength or muscle mass, so it is not expected to reverse fixed weakness that can develop over years. Because these conditions vary widely and so does response, the label advises reviewing how well it is working after about two months to decide whether to continue. If it helps, it is usually taken long term, and in a year-long extension most people kept their benefit and were able to manage the tingling and thinking side effects. Expect ongoing blood tests for potassium and bicarbonate, and let the prescriber know if attacks become more frequent or severe.

Questions to Ask Your Doctor

  1. 1.Is dichlorphenamide a better fit for my type of periodic paralysis than acetazolamide or other options, and why?
  2. 2.How will we judge whether it is working after the first couple of months, and what would make us stop or change the dose?
  3. 3.How often will I need potassium and bicarbonate blood tests, and what should I do about potassium supplements or my diet?
  4. 4.Can I take aspirin, pain relievers or my other medicines safely with it?
  5. 5.What should I do if I develop tingling, memory problems or a fall, and how would this medicine fit with plans for pregnancy?

Last reviewed • Oct 2026

Educational content, not medical advice.